Stay updated on Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.
Latest updates to the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check17 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check46 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for inquiries about joining the study and includes a reference to the Contacts and Locations section in the How to Read a Study Record.SummaryDifference0.8%
- Check60 days agoChange DetectedNew dates have been added for November 2024, while several links related to ovarian cancer and clinical trials have been removed, indicating a potential shift in focus or content availability.SummaryDifference2%
- Check68 days agoChange DetectedThe website has been updated to version 2.12.2, with numerous new resources added related to ovarian cancer, clinical trials, and treatment options, while the previous version 2.12.1 has been removed.SummaryDifference2%
Stay in the know with updates to Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.